{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T16:15:52Z","timestamp":1790180152674,"version":"4.1.0"},"reference-count":55,"publisher":"Informa UK Limited","issue":"4","license":[{"start":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T00:00:00Z","timestamp":1446163200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100012543","name":"Shanghai Science and Technology Foundation","doi-asserted-by":"crossref","award":["97A49"],"award-info":[{"award-number":["97A49"]}],"id":[{"id":"10.13039\/100012543","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Future Sci. OA"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.4155\/fso.15.80","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T13:40:00Z","timestamp":1446212400000},"update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":27,"title":["Pharmacogenetics of Cancer Therapy: Breakthroughs From Beyond?"],"prefix":"10.1080","volume":"1","author":[{"given":"Da-Yong","family":"Lu","sequence":"first","affiliation":[{"name":"School of Life Sciences, Shanghai University, Shanghai200444, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting-Ren","family":"Lu","sequence":"additional","affiliation":[{"name":"School of Life Sciences, Shanghai University, Shanghai200444, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Xu","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai201203, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Ding","sequence":"additional","affiliation":[{"name":"Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Shanghai201203, PR China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2015,10,30]]},"reference":[{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21254"},{"issue":"1","key":"e_1_3_2_4_1","first-page":"6","article-title":"Social aspects of cancer genesis","volume":"8","author":"Ali I","year":"2011","unstructured":"Ali I , Rahis-ud-din, SaleemKet al. Social aspects of cancer genesis. Cancer Ther.8(1), 6\u201314 (2011).","journal-title":"Cancer Ther."},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrg1428"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.20002"},{"issue":"2","key":"e_1_3_2_7_1","first-page":"99","article-title":"Cancer pharmacogenomics: current and future applications","volume":"1603","author":"Watters JW","year":"2003","unstructured":"Watters JW , McleodHL. Cancer pharmacogenomics: current and future applications. Biochim. Biophys. Acta1603(2), 99\u2013111 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmthera.2005.02.005"},{"key":"e_1_3_2_9_1","first-page":"199","volume-title":"Hypotheses in Clinical Medicine","author":"Lu DY","year":"2013","unstructured":"Lu DY , LuTR, ChenXL, DingJ. Chapter 13: individualized cancer chemotherapy. In: Hypotheses in Clinical Medicine. ShojaMM, AgutterPS, TubbsRSet al.Eds). Nova Science Publisher, USA, 199\u2013216 (2013)."},{"issue":"2","key":"e_1_3_2_10_1","first-page":"108","article-title":"Personalized cancer therapy: a perspective","volume":"4","author":"Lu DY","year":"2014","unstructured":"Lu DY , LuTR, WuHY. Personalized cancer therapy: a perspective. Int. J. Pharm. Pract. Drug Res.4(2), 108\u2013118 (2014).","journal-title":"Int. J. Pharm. Pract. Drug Res."},{"issue":"4","key":"e_1_3_2_11_1","first-page":"458","article-title":"Individualized cancer therapy","volume":"2","author":"Lu DY","year":"2014","unstructured":"Lu DY , LuTR, WuHY, CheJY. Individualized cancer therapy. Innovations Pharm. Pharmacother.2(4), 458\u2013469 (2014).","journal-title":"Innovations Pharm. Pharmacother."},{"key":"e_1_3_2_12_1","volume-title":"Personalized Cancer Chemotherapy: An Effective Way of Enhancing the Outcomes in Clinics.","author":"Lu DY","year":"2014","unstructured":"Lu DY . Personalized Cancer Chemotherapy: An Effective Way of Enhancing the Outcomes in Clinics.LuDY (Ed.). Woodhead Publishing, Elsevier, UK (2014)."},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.14.41"},{"key":"e_1_3_2_14_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2006.11.001"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-10-1040"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.4172\/2168-9296.1000e110"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.09.024"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.2174\/1574885511308010003"},{"key":"e_1_3_2_19_1","volume-title":"Cancer Stem Cells","author":"Farrar WL","year":"2011","unstructured":"Farrar WL . Cancer Stem Cells. FarrarWL (Ed.). Cambridge University Press, NY, USA (2011)."},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.4081\/dts.2012.e10"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s40139-013-0036-5"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1203543"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2499"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.03.003"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2011.02.013"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.78.10.6226"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tips.2013.06.005"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/bmc.2953"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.2217\/17410541.2.4.325"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbcan.2006.10.003"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1097\/CAD.0b013e3280109411"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.88"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.79"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.2217\/pme.12.100"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.90"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.213"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11033-012-2241-4"},{"key":"e_1_3_2_38_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.48"},{"issue":"5","key":"e_1_3_2_39_1","first-page":"e121","article-title":"Individualized cancer chemotherapy by detecting cancer biomarkers","volume":"2","author":"Lu DY","year":"2012","unstructured":"Lu DY , LuTR, CaoS. Individualized cancer chemotherapy by detecting cancer biomarkers. Metabolomics2(5), e121 (2012).","journal-title":"Metabolomics"},{"issue":"2","key":"e_1_3_2_40_1","first-page":"e133","article-title":"Cancer bioinformatics, its impacts on cancer therapy","volume":"5","author":"Lu DY","year":"2015","unstructured":"Lu DY , LuTR, ChenXL, ChenEH, DingJ, XuB. Cancer bioinformatics, its impacts on cancer therapy. Metabolomics5(2), e133 (2015).","journal-title":"Metabolomics"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.2217\/pgs.13.81"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1038\/464674a"},{"key":"e_1_3_2_43_1","doi-asserted-by":"publisher","DOI":"10.1038\/464676a"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature09792"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.1038\/bcj.2013.26"},{"issue":"4","key":"e_1_3_2_46_1","first-page":"153","article-title":"Combination chemical agents with biological means in cancer therapy","volume":"7","author":"Lu DY","year":"2013","unstructured":"Lu DY , LuTR, WuHY. Combination chemical agents with biological means in cancer therapy. Res. Rev. BioSci.7(4), 153\u2013155 (2013).","journal-title":"Res. Rev. BioSci."},{"issue":"4","key":"e_1_3_2_47_1","first-page":"134","article-title":"Drug combinations in cancer treatment","volume":"3","author":"Lu DY","year":"2013","unstructured":"Lu DY , LuTR, CaoS. Drug combinations in cancer treatment. Clinical Experimental Pharmacol.3(4), 134 (2013).","journal-title":"Clinical Experimental Pharmacol."},{"issue":"5","key":"e_1_3_2_48_1","first-page":"e121","article-title":"Cost\u2013effectiveness considerations of individualized cancer chemotherapy","volume":"2","author":"Lu DY","year":"2013","unstructured":"Lu DY , LuTR, WuHY. Cost\u2013effectiveness considerations of individualized cancer chemotherapy. Adv. Pharmacoepidemiol. Drug Saf.2(5), e121 (2013).","journal-title":"Adv. Pharmacoepidemiol. Drug Saf."},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2010.02.035"},{"key":"e_1_3_2_50_1","doi-asserted-by":"publisher","DOI":"10.2217\/pme.12.99"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.2174\/187152010793498654"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.3797\/scipharm.1205-01"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.971.11.3"},{"key":"e_1_3_2_54_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.060929"},{"issue":"6","key":"e_1_3_2_55_1","first-page":"465","article-title":"An overview of enhancing the international competitiveness for drug researches, development and manufactures in China","volume":"4","author":"Lu DY","year":"2009","unstructured":"Lu DY , LuTR, WuHY. An overview of enhancing the international competitiveness for drug researches, development and manufactures in China. Chin. Med. Biotechnol.4(6), 465\u2013467 (2009).","journal-title":"Chin. Med. Biotechnol."},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bcp.2013.06.020"},{"issue":"2","key":"e_1_3_2_57_1","first-page":"e134","article-title":"Anticancer drug development, a matter of money or a matter of idea?","volume":"5","author":"Lu DY","year":"2015","unstructured":"Lu DY , ChenEH, LuTR. Anticancer drug development, a matter of money or a matter of idea?Metabolomics5(2), e134 (2015).","journal-title":"Metabolomics"}],"container-title":["Future Science OA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.4155\/fso.15.80","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T02:47:30Z","timestamp":1719110850000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.4155\/fso.15.80"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10,30]]},"references-count":55,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["10.4155\/fso.15.80"],"URL":"https:\/\/doi.org\/10.4155\/fso.15.80","relation":{},"ISSN":["2056-5623"],"issn-type":[{"value":"2056-5623","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,10,30]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=ifso20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2015-10-30","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"FSO80"}}